ACE2-Mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Xia, Huijing ^a   Suda, Sonia ^a   Bindom, Sharell ^a   Feng, Yumei ^a,b   Gurley, Susan B ^c   Seth, Dale ^b   Navar, L Gabriel ^b   Lazartigues, Eric ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DYSAUTONOMIA; ENZYME ACTIVITY; GENE DELETION; GENE OVEREXPRESSION; GENE THERAPY; GENOTYPE; HYPERTENSION; IN VIVO STUDY; MALE; MEDULLA OBLONGATA; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PARAVENTRICULAR THALAMIC NUCLEUS; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; SYMPATHETIC TONE; ADRENERGIC SYSTEM; AGING; ANIMAL; BLOOD PRESSURE; BRAIN; DRUG EFFECT; ENZYMOLOGY; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE; VAGUS NERVE;

MUS;

AGING; ANGIOTENSIN II; ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BRAIN; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM; GENE DELETION; GENE THERAPY; MALE; MICE; MYOCARDIUM; NADPH OXIDASE; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; PRIMARY DYSAUTONOMIAS; REACTIVE OXYGEN SPECIES; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE;

EID: 79960810124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022682     Document Type: Article

References (52)

1. Hirooka Y, Sagara Y, Kishi T, Sunagawa K, (2010) Oxidative stress and central cardiovascular regulation.- Pathogenesis of hypertension and therapeutic aspects. Circ J 74: 827-835.
2. Harrison DG, Gongora MC, (2009) Oxidative stress and hypertension. Med Clin North Am 93: 621-635.
3. Hitomi H, Kiyomoto H, Nishiyama A, (2007) Angiotensin II and oxidative stress. Curr Opin Cardiol 22: 311-315.
4. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL, (2004) Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216.
5. Erdos B, Broxson CS, King MA, Scarpace PJ, Tumer N, (2006) Acute pressor effect of central angiotensin II is mediated by NAD(P)H-oxidase-dependent production of superoxide in the hypothalamic cardiovascular regulatory nuclei. J Hypertens 24: 109-116.
6. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, et al. (2004) NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 24: 5516-5524.
7. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, et al. (2004) Increased Reactive Oxygen Species in Rostral Ventrolateral Medulla Contribute to Neural Mechanisms of Hypertension in Stroke-Prone Spontaneously Hypertensive Rats. Circulation 109: 2357-2362.
8. Fujita M, Ando K, Nagae A, Fujita T, (2007) Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Salt-Sensitive Hypertension. Hypertension 50: 360-367.
9. Pan Y-X, Gao L, Wang W-Z, Zheng H, Liu D, et al. (2007) Exercise Training Prevents Arterial Baroreflex Dysfunction in Rats Treated With Central Angiotensin II. Hypertension 49: 519-527.
10. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, et al. (2004) Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95: 532-539.
11. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9.
12. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, et al. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243.
13. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, et al. (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol- Regul Integr Comp Physiol 292: R373-R381.
14. Feng Y, Yue X, Xia H, Bindom SM, Hickman PJ, et al. (2008) Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II-Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation. Circ Res 102: 729-736.
15. Lin Z, Chen Y, Zhang W, Chen AF, Lin S, et al. (2008) RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin-converting enzyme 2. Exp Physiol 93: 676-684.
16. Xia H, Feng Y, Obr TD, Hickman PJ, Lazartigues E, (2009) Angiotensin II Type 1 Receptor Mediated Reduction of Angiotensin-Converting Enzyme 2 activity in the Brain Impairs Baroreflex Function in Hypertensive Mice. Hypertension 53: 210-216.
17. Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK, (2007) Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats. Hypertension 49: 926-931.
18. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, et al. (2010) Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 106: 373-382.
19. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, et al. (2007) Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 75: 29-39.
20. Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, et al. (2010) Angiotensin-(1-7)-Angiotensin-Converting Enzyme 2 Attenuates Reactive Oxygen Species Formation to Angiotensin II Within the Cell Nucleus. Hypertension 55: 166-171.
21. Zhong J-C, Yu X-Y, Lin Q-X, Li X-H, Huang X-Z, et al. (2008) Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Br J Pharmacol 153: 66-74.
22. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, et al. (2006) Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 116: 2218-2225.
23. Zou L-X, Hymel A, Imig JD, Navar LG, (1996) Renal Accumulation of Circulating Angiotensin II in Angiotensin II-Infused Rats. Hypertension 27: 658-662.
24. Zou LX, Iming JD, Hymel A, Navar LG, (1998) Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor. Am J Hypertens 11: 570-578.
25. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277: 14838-14843.
26. Davisson RL, (2003) Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol- Regul Integr Comp Physiol 285: R498-R511.
27. Kim-Mitsuyama S, Yamamoto E, Tanaka T, Zhan Y, Izumi Y, et al. (2005) Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive Rats. Stroke 36: 1077-1082.
28. Gallagher PE, Ferrario CM, Tallant EA, (2008) MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol Cell Physiol 295: C1169-C1174.
29. Gallagher PE, Ferrario CM, Tallant EA, (2008) Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Cir Physiol 295: H2373-H2379.
30. Li P, Chappell MC, Ferrario CM, Brosnihan KB, (1997) Angiotensin-(1-7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric Oxide. Hypertension 29: 394-398.
31. Gironacci MM, Valera MS, Yujnovsky I, Pena C, (2004) Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats. Hypertension 44: 783-787.
32. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, et al. (2007) Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent Pathways. Hypertension 49: 185-192.
33. Yang R, Yin J, Li Y, Zimmerman M, Schultz H, (2011) Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am J Physiol Cell Physiol 300: C58-C64.
34. Benter IF, Yousif MHM, Dhaunsi GS, Kaur J, Chappell MC, et al. (2008) Angiotensin-(1-7) Prevents Activation of NADPH Oxidase and Renal Vascular Dysfunction in Diabetic Hypertensive Rats. Am J Nephrol 28: 25-33.
35. Polizio AH, Gironacci MM, Tomaro ML, Pena C, (2007) Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production. Pharmacol Res 56: 86-90.
36. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, et al. (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828.
37. Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, et al. (2006) Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II. Hypertension 47: 718-726.
38. Chapleau MW, Abboud FM, (2001) Neuro-cardiovascular regulation: from molecules to man. Ann N Y Acad Sci 940: xiii-xxii.
39. Gao L, Wang W, Li YL, Schultz HD, Liu D, et al. (2004) Superoxide Mediates Sympathoexcitation in Heart Failure: Roles of Angiotensin II and NAD(P)H Oxidase. Circ Res 95: 937-944.
40. Guyenet PG, (2006) The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346.
41. Kyaw M, Yoshizumi M, Tsuchiya K, Izawa Y, Kanematsu Y, et al. (2004) Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. Acta Pharmacol Sin 25: 977-985.
42. Blagosklonny M, (2008) Aging: ROS or TOR. Cell Cycle 7: 3344-3354.
43. Powers R, Kaeberlein M, Caldwell S, Kennedy B, Fields S, (2006) Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev 20: 174-184.
44. Vellai T, Takacs-Vellai K, zhang Y, Kovacs A, Orosz L, et al. (2003) Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426: 620.
45. Kapahi P, Zid B, Harper T, Koslover D, Sapin V, et al. (2004) Regulation of Lifespan in Drosophila by Modulation of Genes in the TOR Signaling Pathway. Curr Biol 14: 885-890.
46. Hafizi S, Wang X, Chester A, Yacoub M, Proud C, (2004) ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am J Physiol Heart Cir Physiol 287: H1232-H1238.
47. Arsham A, Howell J, Simon M, (2003) A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 278: 29655-29660.
48. Schieke S, Phillips D, McCoy J, Aponte A, Shen R, et al. (2006) The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281: 27643-27652.
49. Vinciguerra M, Santini M, Claycomb W, Ladurner A, Rosenthal N, (2009) Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging 2: 43-62.
50. Hsieh C, Kuro-o M, Rosenblatt K, Brobey R, Papaconstantinou J, (2010) The ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging 2: 597-611.
51. Gurley SB, Coffman TM, (2008) Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages. Exp Physiol 93: 538-542.
52. Whitaker A, Feng Y, Lazartigues E, (2007) Central AT1 receptor blockade restores baroreflex sensitivity and lowers blood pressure in ACE2 knockout mice. FASEB J 21: A889.